This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0269881108089598v1 23/4/442    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Walf, A. A. Articles by Frye, C. A. Search for Related Content PubMed PubMed Citation Articles by Walf, A. A. Articles by Frye, C. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Depression Hazardous Substances DB ESTRADIOL Social Bookmarking                         What's this?

Adult female wildtype, but not oestrogen receptor knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile

¹ Department of Psychology, The University at Albany – State University of New York, Albany, New York, USA
² Department of Psychology, The University at Albany – State University of New York, Albany, New York, USA; Department of Biological Sciences, The University at Albany – State University of New York, Albany, New York, USA; The Center for Neuroscience, The University at Albany – State University of New York, Albany, New York, USA; The Center for Life Sciences, The University at Albany – State University of New York, Albany, New York, USA

^* To whom correspondence should be addressed.

	Abstract

Abstract

Studies in people and animal models suggest that depression is influenced by natural fluctuations in the levels of 17-oestradiol (E₂), as well as administration of E₂-based therapies, such as selective oestrogen receptor modulators (SERMs). Elucidating the effects and mechanisms of E₂ is important to improve future E₂-based therapeutics. An important question is whether effects of E₂ or SERMs for mood regulation act at the or isoform of the oestrogen receptor (ER) because some of the unwanted trophic effects of E₂-based therapies may involve actions at ER, rather than ER. In the present study, whether there are sex differences in depression-like behaviour of adult mice (experiment 1), and the effects of natural fluctuations in E₂ (experiment 2), or administration of E₂ or a SERM that has higher affinity for ER than for ER (diarylpropionitrile; DPN) to ovariectomised (experiment 3) wildtype and ER knockout (ERKO) mice were investigated. Results of this study supported our hypotheses that: there would be sex differences favouring males for depression-like behaviour and endogenous increases in, or exogenous administration of, E₂ or administration of an ER SERM would decrease depression-like behaviour in wildtype, but not ERKO, mice. In experiment 1, adult male mice spent less time immobile in the forced swim test (i.e., showed less depression-like behaviour) compared with female mice. In experiment 2, pro-oestrous (higher circulating E₂ levels), compared with dioestrous (lower circulating E₂ levels), mice had reduced immobility in the forced swim test; this effect was not observed in ERKO mice. In experiment 3, administration of E₂ or DPN to ovariectomised wildtype, but not ERKO, mice decreased immobility compared with vehicle administration, these data suggest that ER may be required for some of the anti–depressant-like effects of E₂.

Key Words: affect, oestrogen, oestrous cycle, SERMs, sex differences

First published on June 18, 2008, doi:10.1177/0269881108089598

Journal of Psychopharmacology 2009;23:442.

A more recent version of this article appeared on June 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?